Drug recall · October 19, 2016
Marcaine 0.25% recall
Why: Lack of Assurance of Sterility and Subpotent Drug: defect in glass vial prevented stopper from forming a seal allowing water to ingress and dilute the product causing it to be less than the labeled potency.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Marcaine 0.25% (bupivacaine HCl) injection, USP, 125 mg/50 mL (2.5 mg/mL), 50 mL Multiple-Dose Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1587-50.
- Lots / codes
Lot #: 60295DD, Ep 1DEC2017
- Quantity
- 15 vials
- Company
- Hospira Inc., A Pfizer Company, Lake Forest, IL
- Distribution
- Nationwide and Puerto Rico
- Initiated
- September 16, 2016 · Voluntary: Firm initiated
- Classified
- October 13, 2016
- Reported
- October 19, 2016
- Ended
- July 31, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Bupivacaine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.